Michal Weitman

1.2k total citations
48 papers, 984 citations indexed

About

Michal Weitman is a scholar working on Molecular Biology, Materials Chemistry and Electrical and Electronic Engineering. According to data from OpenAlex, Michal Weitman has authored 48 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Materials Chemistry and 7 papers in Electrical and Electronic Engineering. Recurrent topics in Michal Weitman's work include Plant biochemistry and biosynthesis (5 papers), Pharmacological Effects of Natural Compounds (4 papers) and HIV/AIDS drug development and treatment (4 papers). Michal Weitman is often cited by papers focused on Plant biochemistry and biosynthesis (5 papers), Pharmacological Effects of Natural Compounds (4 papers) and HIV/AIDS drug development and treatment (4 papers). Michal Weitman collaborates with scholars based in Israel, United States and France. Michal Weitman's co-authors include Dan Thomas Major, Jiali Gao, Mudit Dixit, Abraham Nudelman, Bilha Fischer, Amnon Hizi, Ada Rephaeli, Alon Herschhorn, Michal Afri and Hugo E. Gottlieb and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

Michal Weitman

48 papers receiving 955 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michal Weitman Israel 19 444 195 193 160 140 48 984
Liming Zhou China 16 328 0.7× 139 0.7× 238 1.2× 605 3.8× 386 2.8× 46 1.7k
Jae Kyun Lee South Korea 22 342 0.8× 120 0.6× 213 1.1× 997 6.2× 215 1.5× 96 1.8k
Jingjing Yan China 20 298 0.7× 116 0.6× 328 1.7× 357 2.2× 472 3.4× 60 1.3k
Li Shen China 19 305 0.7× 236 1.2× 175 0.9× 336 2.1× 433 3.1× 67 1.3k
Renaud Hardré France 21 348 0.8× 63 0.3× 63 0.3× 224 1.4× 170 1.2× 42 1.0k
Vartika Tomar India 16 374 0.8× 57 0.3× 175 0.9× 248 1.6× 256 1.8× 29 1.0k
Matthias Grüne Germany 23 287 0.6× 87 0.4× 135 0.7× 621 3.9× 541 3.9× 36 1.5k
Khashayar Karimian Iran 19 379 0.9× 38 0.2× 218 1.1× 245 1.5× 98 0.7× 54 1.1k
Rajendra K. Sharma India 17 401 0.9× 103 0.5× 46 0.2× 449 2.8× 63 0.5× 77 909
Ramesh Chandra India 21 577 1.3× 51 0.3× 235 1.2× 436 2.7× 180 1.3× 88 1.3k

Countries citing papers authored by Michal Weitman

Since Specialization
Citations

This map shows the geographic impact of Michal Weitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Weitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Weitman more than expected).

Fields of papers citing papers by Michal Weitman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Weitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Weitman. The network helps show where Michal Weitman may publish in the future.

Co-authorship network of co-authors of Michal Weitman

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Weitman. A scholar is included among the top collaborators of Michal Weitman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Weitman. Michal Weitman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Unger, Tamar, Shira Albeck, Gary Weisinger, et al.. (2024). Treating late-onset Tay Sachs disease: Brain delivery with a dual trojan horse protein. Molecular Therapy — Methods & Clinical Development. 32(3). 101300–101300. 2 indexed citations
2.
Ben‐Horin, Shomron, Nir Salomon, N. Viazis, et al.. (2023). P560 Curcumin-QingDai combination for patients with active ulcerative colitis: A randomized double-blinded placebo-controlled trial. Journal of Crohn s and Colitis. 17(Supplement_1). i691–i691. 2 indexed citations
3.
Guez-Haddad, Julia, Michal Weitman, Ran Zalk, et al.. (2023). Structure-function analysis of ceTIR-1/hSARM1 explains the lack of Wallerian axonal degeneration in C. elegans. Cell Reports. 42(9). 113026–113026. 5 indexed citations
4.
Ben‐Horin, Shomron, Nir Salomon, Nikos Viazis, et al.. (2023). Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled Trial. Clinical Gastroenterology and Hepatology. 22(2). 347–356.e6. 29 indexed citations
5.
Weitman, Michal, Arik Eisenkraft, Zeev Tashma, et al.. (2022). Synthesis and preliminary biological evaluation of gabactyzine, a benactyzine-GABA mutual prodrug, as an organophosphate antidote. Scientific Reports. 12(1). 18078–18078. 2 indexed citations
6.
Guez-Haddad, Julia, Michal Weitman, A.N. Plotnikov, et al.. (2022). A duplex structure of SARM1 octamers stabilized by a new inhibitor. Cellular and Molecular Life Sciences. 80(1). 16–16. 10 indexed citations
7.
Levy, Natasha Ronith, Jonathan Tzadikov, Michal Weitman, et al.. (2021). Molten state synthesis of nickel phosphides: mechanism and composition-activity correlation for electrochemical applications. Journal of Materials Chemistry A. 9(48). 27629–27638. 14 indexed citations
8.
Weitman, Michal, et al.. (2021). Comparison of the tissue distribution and metabolism of AN1284, a potent anti-inflammatory agent, after subcutaneous and oral administration in mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 394(10). 2077–2089. 1 indexed citations
9.
Attias, Ran, Michal Weitman, Yuval Elias, et al.. (2021). Developing Effective Electrodes for Supercapacitors by Grafting of Trihydroxybenzene onto Activated Carbons. Journal of The Electrochemical Society. 168(5). 50520–50520. 3 indexed citations
10.
Nimkar, Amey, Bar Gavriel, Meital Turgeman, et al.. (2021). Influences of Cations’ Solvation on Charge Storage Performance in Polyimide Anodes for Aqueous Multivalent Ion Batteries. ACS Energy Letters. 6(7). 2638–2644. 31 indexed citations
11.
Shpigel, Netanel, Fyodor Malchik, Mikhael D. Levi, et al.. (2020). New aqueous energy storage devices comprising graphite cathodes, MXene anodes and concentrated sulfuric acid solutions. Energy storage materials. 32. 1–10. 41 indexed citations
12.
Permyakova, Anna, et al.. (2020). A Novel Indoline Derivative Ameliorates Diabesity-Induced Chronic Kidney Disease by Reducing Metabolic Abnormalities. Frontiers in Endocrinology. 11. 91–91. 8 indexed citations
13.
Weitman, Michal, Yuval Elias, Ran Attias, et al.. (2019). Catechol-Modified Carbon Cloth as Hybrid Electrode for Energy Storage Devices. Journal of The Electrochemical Society. 166(6). A1147–A1153. 9 indexed citations
14.
Moyal, Lilach, Ada Rephaeli, Abraham Nudelman, et al.. (2016). The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin. PLoS ONE. 11(1). e0146115–e0146115. 11 indexed citations
15.
Major, Dan Thomas, et al.. (2014). Catalytic control in terpenoid cyclases: multiscale modeling of thermodynamic, kinetic, and dynamic effects. Current Opinion in Chemical Biology. 21. 25–33. 62 indexed citations
16.
Weitman, Michal, et al.. (2014). Synthesis and in vitro evaluation of anti-inflammatory activity of ester and amine derivatives of indoline in RAW 264.7 and peritoneal macrophages. Bioorganic & Medicinal Chemistry Letters. 24(10). 2283–2287. 26 indexed citations
17.
Tarasenko, Nataly, Suzanne M. Cutts, Don R. Phillips, et al.. (2014). A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo. Biochemical Pharmacology. 88(2). 158–168. 18 indexed citations
18.
Weitman, Michal, et al.. (2012). A multifunctional 5-aminolevulinic acid derivative induces erythroid differentiation of K562 human erythroleukemic cells. European Journal of Pharmaceutical Sciences. 47(1). 206–214. 8 indexed citations
19.
Margulis‐Goshen, Katrin, Michal Weitman, Dan Thomas Major, & Shlomo Magdassi. (2011). Inhibition of crystallization and growth of celecoxib nanoparticles formed from volatile microemulsions. Journal of Pharmaceutical Sciences. 100(10). 4390–4400. 19 indexed citations
20.
Weitman, Michal, et al.. (2011). Multifunctional 5-aminolevulinic acid prodrugs activating diverse cell-death pathways. Investigational New Drugs. 30(3). 1028–1038. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026